CV Sciences, Inc. Share Price Other OTC
Equities
CVSI
US1266541028
Pharmaceuticals
Sales 2022 | 16.2M 1.29B | Sales 2023 | 16M 1.28B | Capitalization | 5.47M 436M |
---|---|---|---|---|---|
Net income 2022 | -9M -717M | Net income 2023 | 3M 239M | EV / Sales 2022 | 0.36 x |
Net Debt 2022 | 917K 73.1M | Net cash position 2023 | 875K 69.75M | EV / Sales 2023 | 0.29 x |
P/E ratio 2022 |
-0.44
x | P/E ratio 2023 |
1.77
x | Employees | - |
Yield 2022 * |
-
| Yield 2023 |
-
| Free-Float | 99.98% |
Latest transcript on CV Sciences, Inc.
Managers | Title | Age | Since |
---|---|---|---|
Joseph Dowling
CEO | Chief Executive Officer | 66 | 15/06/14 |
Joerg Grasser
DFI | Director of Finance/CFO | 49 | 25/12/18 |
Members of the board | Title | Age | Since |
---|---|---|---|
Joseph Dowling
CEO | Chief Executive Officer | 66 | 15/06/14 |
Jamie Corroon
BRD | Director/Board Member | 54 | 20/07/22 |
William McCorkle
BRD | Director/Board Member | 56 | 20/10/22 |
1st Jan change | Capi. | |
---|---|---|
+21.85% | 546B | |
-4.77% | 359B | |
+16.97% | 323B | |
+5.69% | 290B | |
+13.68% | 234B | |
+3.65% | 198B | |
-11.12% | 194B | |
+8.08% | 167B | |
-3.40% | 157B |